Position in NKTX
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$4,465,307
+$1,136,050 QoQ
Shares Held
1,577,847
0.0% QoQ
Ownership
2.20%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#11
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WASATCH ADVISORS LP holds $96,311,805 across 9 Biotechnology names. NKTX ranks #8 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TARS |
Tarsus Pharmaceuticals, Inc.
|
368,568 | $23,197,669 | |
| 2 | CCCC |
C4 Therapeutics, Inc.
|
3,522,644 | $16,450,747 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,307,247 | $14,183,629 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
312,767 | $12,201,040 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
443,668 | $9,853,866 | |
| 6 | MGNX |
Macrogenics Inc
|
2,018,881 | $9,327,230 | |
| 7 | IMTX |
Immatics N.V.
|
441,510 | $4,472,496 | |
| 8 | NKTX |
Nkarta, Inc.
This page
|
1,577,847 | $4,465,307 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,465,307 | 1,577,847 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $3,329,257 | 1,577,847 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $2,916,121 | 1,576,282 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,390,115 | 1,637,737 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,965,115 | 1,786,214 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,801,458 | 2,066,010 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,277,063 | 2,520,909 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,292,753 | 1,834,680 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,230,000 | 1,392,555 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,631,398 | 1,168,492 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $13,858,013 | 2,099,699 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,568,586 | 1,847,904 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,323,303 | 4,713,837 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $13,893,549 | 3,913,676 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $16,377,917 | 2,734,210 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,279,478 | 1,920,933 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,106,055 | 1,631,985 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,585,396 | 842,302 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,695,090 | 631,602 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $14,931,856 | 536,924 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $18,387,995 | 580,246 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $17,082,272 | 519,218 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $26,214,250 | 426,456 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $17,579,658 | 584,819 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||